Medical Cannabis - D-A-CH

D-A-CH

Revenue in the Medical Cannabis market market in D-A-CH is forecasted to hit US$0.62bn by 2024.
The revenue is anticipated to demonstrate an annual growth rate (CAGR 2024-2029) of 3.60%, leading to a market volume of US$0.74bn by 2029.
When compared globally, the United States is expected to generate the highest revenue (US$14,530.00m in 2024).
In terms of per person revenues in relation to total population figures, US$1.70k are generated in D-A-CH in 2024.
In D-A-CH, the Medical Cannabis market is experiencing a surge in investor interest, driving up the demand for Cannabis-related financial commodities.

Key regions: Australia, Europe, South Africa, United States, Netherlands

Market

Region

Region comparison

Currency

Analyst Opinion

The Medical Cannabis market in D-A-CH has been experiencing significant growth and development in recent years.

Customer preferences: Customers in the D-A-CH region are increasingly turning to medical cannabis as an alternative treatment option for various health conditions. The growing awareness about the potential therapeutic benefits of cannabis products has led to a shift in consumer preferences towards natural and holistic remedies.

Trends in the market: In Germany, the largest market in the D-A-CH region, there has been a notable increase in the number of patients obtaining medical cannabis prescriptions. This trend can be attributed to the expanding list of approved medical conditions for which cannabis can be prescribed, as well as the efforts to improve patient access to medical cannabis products.

Local special circumstances: Switzerland, another key market in the D-A-CH region, has a unique regulatory framework that allows for the production and sale of low-THC cannabis products. This has created a niche market for CBD products, which are increasingly popular among consumers seeking the potential health benefits of cannabis without the psychoactive effects.

Underlying macroeconomic factors: The D-A-CH region benefits from a strong economy and healthcare system, which have created a conducive environment for the growth of the medical cannabis market. Additionally, changing attitudes towards cannabis and increasing acceptance of its medicinal properties have played a significant role in driving the expansion of the market in the region.

Methodology

Data coverage:

Data encompasses B2B and B2C enterprises. Figures are based on companies' revenues, funding values and global consumer survey data. Revenues include retail, sales and taxes.

Modeling approach / Market size:

Market sizes are determined by a Top-Down approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use financial reports, third-party data. Next, we use relevant key market indicators and data from country-specific associations such as tobacco spending per capita, medical product spending per capita, consumer spending and consumer spending for recreation purposes, population. This data helps us to estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, S-Curve function, ARIMA time series model and exponential curve function.

Additional Notes:

The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. GCS data is reweighted for representativeness.